Top Markets
Coin of the day
Cortexyme, Inc. Cortexyme, Inc.

Cortexyme, Inc.

CRTX
Rankning i aktier #25182
Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to... Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to pioneering new therapies for Alzheimer's and various other degenerative conditions. The company's primary investigational drug, atuzaginstat (also known as COR388), is an orally delivered, small molecule inhibitor engineered to cross the blood-brain barrier and target gingipain. This compound is currently in Phase II/III clinical trials, where it is being assessed for its potential use in individuals with mild to moderate Alzheimer's disease, as well as for tackling oral squamous cell carcinoma, periodontitis, and coronavirus infections. Established in 2012, Cortexyme, Inc. is headquartered in South San Francisco, California.
Aktiekurs
$1.95
Senast synkroniserad: 2022-07-29
Marknadsvärde
$52.48M
Förändring (1 dag)
2.63%
Förändring (1 år)
0.00%
Land
US
Handel Cortexyme, Inc. (CRTX)

Kategori

Historik för aktiesplit för Cortexyme, Inc. (CRTX)
Aktien Cortexyme, Inc. (symbol: CRTX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 21, 2026.
En CRTX-aktie köpt före Aug 21, 2026 motsvarar nu 0 CRTX-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US